ARTA
SRPT icon

A.R.T. Advisors’s Sarepta Therapeutics SRPT Stock Holding History

A.R.T. Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-34,800
Closed -$2.62M – 1689
2019
Q3 		$2.62M Buy
34,800
+26,100
+300% +$3.08M 0.13% 196
2019
Q2 		$1.32M Buy
+8,700
New +$1.06M 0.07% 356
2019
Q1 		– Sell
-13,500
Closed -$1.47M – 1594
2018
Q4 		$1.47M Buy
+13,500
New +$1.69M 0.09% 320
2018
Q3 		– Sell
-30,300
Closed -$4M – 1690
2018
Q2 		$4M Sell
30,300
-15,700
-34% -$1.48M 0.16% 161
2018
Q1 		$3.41M Buy
46,000
+16,100
+54% +$1.07M 0.14% 204
2017
Q4 		$1.66M Buy
+29,900
New +$1.58M 0.07% 434
2017
Q3 		– Sell
-141,300
Closed -$4.76M – 1640
2017
Q2 		$4.76M Sell
141,300
-20,100
-12% -$654K 0.25% 73
2017
Q1 		$4.78M Buy
+161,400
New +$5M 0.22% 105
2016
Q4 		– Sell
-11,400
Closed -$700K – 1398
2016
Q3 		$700K Sell
11,400
-199,397
-95% -$6.03M 0.23% 128
2016
Q2 		$4.02M Sell
210,797
-171,430
-45% -$3.18M 0.2% 124
2016
Q1 		$7.46M Buy
+382,227
New +$6.68M 0.33% 45
2015
Q4 		– Sell
-91,056
Closed -$2.92M – 1698
2015
Q3 		$2.92M Buy
+91,056
New +$3.09M 0.11% 255
2015
Q2 		– Sell
-66,657
Closed -$885K – 1703
2015
Q1 		$885K Buy
66,657
+37,172
+126% +$495K 0.03% 707
2014
Q4 		$426K Sell
29,485
-351
-1% -$5.94K 0.02% 977
2014
Q3 		$629K Sell
29,836
-43,915
-60% -$991K 0.03% 669
2014
Q2 		$2.2M Buy
+73,751
New +$2.33M 0.11% 257
2014
Q1 		– Sell
-130,965
Closed -$2.67M – 1535
2013
Q4 		$2.67M Buy
+130,965
New +$3.89M 0.14% 199

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

A.R.T. Advisors's SRPT Position: Q4 2019 in Review

A.R.T. Advisors sold out of Sarepta Therapeutics (SRPT) in Q4 2019, closing a stake of 34,800 shares — an estimated $2.62M sold.

A.R.T. Advisors first reported a position in SRPT in Q4 2013 and held it in 17 quarters. The position peaked at $7.46M in Q1 2016. 389 funds tracked by Wall St. Rank hold SRPT as of Q4 2019.

  • A.R.T. Advisors reported no remaining Sarepta Therapeutics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 34,800 Sarepta Therapeutics shares in Q4 2019, an estimated $2.62M.
  • A.R.T. Advisors first reported a position in Sarepta Therapeutics in Q4 2013 and held it in 17 quarters.
  • A.R.T. Advisors's Sarepta Therapeutics position peaked at $7.46M in Q1 2016.
  • 389 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.